Rep. Wyden's FDA reform bill would establish three categories of GMP changes.
This article was originally published in The Tan Sheet
THREE CATEGORIES OF GMP CHANGES WOULD BE CREATED UNDER FDA REFORM BILL introduced by Rep. Ron Wyden (D-Ore.) on June 6. The primary intent of the section called "Rationalizing Good Manufacturing Practices" is to create three categories of manufacturing changes: (1) those that require FDA preclearance; (2) those that require a sponsor to notify FDA 30 days prior to implementation (for which no active approval is needed from the agency); and (3) those which require mention to FDA in annual reports.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC